ARCHIVES

Sorafenib Targets AML Driven By Mutant FLT3 Gene

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Non-Caucasians At Higher Risk For Severe Breast Cancer Pain

December 28, 2007

BSA Working Group

November 12, 2010

OD Contract Concepts Okayed

October 17, 1986

In Brief: Rogers On AHF Board; GAO Says Legislation May Needed For Hospice Reimbursement

March 23, 1979

Bishop: Cells, Genes Reveal Unified Strategy For Cancer Conquest

March 3, 1995

In Brief: 896 Nurses Pass Oncology Certification Exam; ACS Awards 375 New Grants Worth $43.8 Million

July 6, 1990